The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: An update by meta-analysis of 53 individual studies

Gene

Volumn 510, Issue 2, 2012, Pages 93-101

  Zhang, Kui ^a   Zhou, Bin ^b   Wang, Yanyun ^b   Rao, Li ^c   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; Single nucleotide polymorphism; X ray repair cross complementing group 1

Indexed keywords

ARGININE; HISTIDINE; XRCC1 PROTEIN;

ALLELE; CANCER RISK; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; ETHNICITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PRIORITY JOURNAL; REVIEW; SMOKING; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84867329087     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.08.039     Document Type: Review

References (72)

1. Aiwu L., Kai L., Mingyu Y., Lijian X., Jiacheng X. Correlation of polymorphism of DNA repair gene XRCC1 with susceptibility to gastric cancer in Shandong Province. Chin. J. Cancer Prev. Treat. 2009, 16:489-493.
2. Applebaum K.M., McClean M.D., Nelson H.H., Marsit C.J., Christensen B.C., Kelsey K.T. Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int. J. Cancer 2009, 124:2690-2696.
3. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
4. Burri R.J., et al. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat. Res. 2008, 170:49-59.
5. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst.) 2003, 2:955-969.
6. Chacko P., Rajan B., Joseph T., Mathew B.S., Pillai M.R. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res. Treat. 2005, 89:15-21.
7. Chang-Claude J., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin. Cancer Res. 2005, 11:4802-4809.
8. Chiang F.Y., et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin. Cancer Res. 2008, 14:5919-5924.
9. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
10. Dominguez I., Daza P., Natarajan A.T., Cortes F. A high yield of translocations parallels the high yield of sister chromatid exchanges in the CHO mutant EM9. Mutat. Res. 1998, 398:67-73.
11. Fan J., Otterlei M., Wong H.K., Tomkinson A.E., Wilson D.M. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res. 2004, 32:2193-2201.
12. Fard-Esfahani P., et al. Association of Arg194Trp, Arg280His and Arg399Gln polymorphisms in X-ray repair cross-complementing group 1 gene and risk of differentiated thyroid carcinoma in Iran. Iran. Biomed. J. 2011, 15:73-78.
13. Figueroa J.D., et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genet. 2007, 121:233-242.
14. Garcia-Quispes W.A., et al. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat. Res. 2011, 709-710:67-72.
15. Hao B., et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004, 64:4378-4384.
16. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
17. Hong Y.C., et al. Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int. J. Cancer 2005, 116:428-432.
18. Hsu L.I., et al. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan. Toxicol. Appl. Pharmacol. 2008, 228:144-155.
19. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1810-1818.
20. Huang J., Ye F., Chen H., Lu W., Xie X. The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection. Int. J. Gynecol. Cancer 2007, 17:668-675.
21. Huang W.Y., et al. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 2008, 29:100-105.
22. Huang Y., Li L., Yu L. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 2009, 24:331-339.
23. Hung R.J., et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. 2005, 97:567-576.
24. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162:925-942.
25. Juan J.M., Kun C., Shuang Z.S. Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer. J. Zhejiang Univ. Med. Sci. 2006, 35:370-376.
26. Juan J.M., Kun C., Yang Z., Wei Z., Bing L., Jing Z.Y. Correlations of single nucleotide polymorphisms of DNA repair gene XRCC1 to risk of colorectal cancer. Chin. J. Cancer 2007, 26:274-279.
27. Kang S.Y., et al. Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population. Cancer Sci. 2007, 98:716-720.
28. Kim I.S., et al. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population. Cancer Genet. Cytogenet. 2010, 196:31-37.
29. Kim I.S., et al. Polymorphisms and haplotypes in the XRCC1 gene and the risk of advanced non-small cell lung cancer. J. Thorac. Oncol. 2010, 5:1912-1921.
30. Kiran M., Saxena R., Chawla Y.K., Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol. Cell. Biochem. 2009, 327:7-13.
31. Kiuru A., et al. Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations. Environ. Mol. Mutagen. 2005, 46:198-205.
32. Lee J.M., et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer 2001, 95:240-246.
33. Lee S.G., Kim B., Choi J., Kim C., Lee I., Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett. 2002, 187:53-60.
34. Li M., et al. XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer 2008, 62:145-151.
35. Lindahl T., Wood R.D. Quality control by DNA repair. Science 1999, 286:1897-1905.
36. Liu J., et al. DNA repair gene XRCC1 polymorphisms and non-Hodgkin lymphoma risk in a Chinese population. Cancer Genet. Cytogenet. 2009, 191:67-72.
37. Loizidou M.A., et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat. 2008, 112:575-579.
38. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
39. Metsola K., et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res. 2005, 7:R987-R997.
40. Meza-Espinoza J.P., et al. XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet. Mol. Res. 2009, 8:1451-1458.
41. Misra R.R., et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003, 191:171-178.
42. Moreno V., et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin. Cancer Res. 2006, 12:2101-2108.
43. Moullan N., Cox D.G., Angele S., Romestaing P., Gerard J.P., Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1168-1174.
44. Nan D.Y., lan S.D., Na W., Miao Z.R., Yan L. Association of XRCC1 Polymorphism with Risk of Gastric Cardiac Adenocarcinoma. Cancer Res. Prev. Treat. 2009, 36:1067-1071.
45. Pachkowski B.F., Winkel S., Kubota Y., Swenberg J.A., Millikan R.C., Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res. 2006, 66:2860-2868.
46. Qiong D., li Y.Y., Y.Z.h Association of the DNA repair gene genetic polymorphisms and risk of nasopharyngeal carcinoma in Sichuan Luzhou population. Guangdong Med. J. 2007, 28:513-515.
47. Ratnasinghe D., et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001, 10:119-123.
48. Sak S.C., Barrett J.H., Paul A.B., Bishop D.T., Kiltie A.E. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet. 2007, 8:13.
49. Sangrajrang S., et al. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res. Treat. 2008, 111:279-288.
50. Shaoli D., Ming C., Wei C., Weiping L., Hengliu H., Ji X. Association of DNA repair gene polymorphisms with genetic susceptibility to gastric cancer. J. Mol. Diagn. Ther. 2010, 2:371-374.
51. Siraj A.K., et al. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J. Endocrinol. Invest. 2008, 31:893-899.
52. Skjelbred C.F., et al. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer 2006, 6:67.
53. Smith T.R., et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008, 29:2132-2138.
54. Stern M.C., Umbach D.M., van Gils C.H., Lunn R.M., Taylor J.A. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001, 10:125-131.
55. Takanami T., Nakamura J., Kubota Y., Horiuchi S. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability. Mutat. Res. 2005, 582:135-145.
56. van Gils C.H., Bostick R.M., Stern M.C., Taylor J.A. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1279-1284.
57. Vogel U., Nexo B.A., Wallin H., Overvad K., Tjonneland A., Raaschou-Nielsen O. No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem. Genet. 2004, 42:453-460.
58. Wang C., Sun Y., Han R. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Urology 2008, 72:869-872.
59. Wang B., Wang D., Huang G., Zhang C., Xu D.H., Zhou W. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int. J. Colorectal Dis. 2010, 25:313-321.
60. Wang M., et al. Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol. 2010, 29:303-311.
61. Wu M.T., et al. No association between polymorphisms of the DNA repair geneXRCC1 and cervical neoplasm risk. Environ. Health Prev. Med. 2003, 8:100-103.
62. Xiaoqing W., Zhihui Y. Association of XRCC1 polymorphism with risk of cervical cancer. Mod. Med. Health 2010, 26:2137-2138.
63. Xu Z., et al. Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China. Asian J. Androl. 2007, 9:331-338.
64. Xue H., Ni P., Lin B., Xu H., Huang G. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and meta-analysis. Am. J. Epidemiol. 2011, 173:363-375.
65. Yan L., Yanan D., Donglan S., Na W., Rongmiao Z., Zhifeng C. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis. Esophagus 2009, 22:396-401.
66. Yang Y., Zhai X.D., Gao L.B., Li S.L., Wang Z., Chen G.D. Genetic polymorphisms of DNA repair gene XRCC1 and risk of uterine leiomyoma. Mol. Cell. Biochem. 2010, 338:143-147.
67. Yin J., Vogel U., Ma Y., Qi R., Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet. Cytogenet. 2009, 188:26-31.
68. Yin G., et al. Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan. J. Epidemiol. 2012, 22:64-71.
69. Yun Z.X., Ping Y.H., Qiang Q.X., Long J., Man L.L. A case-control study of polymorphismof XRCC1 gene and the risk of hepatocellular carcinoma. Chin. J. Dis. Control Prev. 2010, 14:760-763.
70. Zhang Y., et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15:353-358.
71. Zhou W., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2003, 12:359-365.
72. Zienolddiny S., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27:560-567.